Karyopharm Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.1% | +44.7% | -95.6% | +0.0% | +51,033.3% | +551.9% | +98.9% | -98.8% | -13.8% | -24.8% | +6,024.5% | +38.5% | +37.6% | +0.2% | +84.8% | -36.3% | +64.5% | -33.7% | -2.8% | +66.8% | +235.0% | -62.2% | -16.8% | -8.9% | -7.1% | +15.2% | -2.9% | -4.2% | -6.3% | -1.8% | +29.2% | -9.4% | -21.2% | -1.7% | +26.4% | +16.1% | -22.6% | +2.9% | -4.7% | – | |
| – | +3.9% | +16.5% | -4.0% | +9.2% | +38.0% | +18.6% | +8.3% | -18.6% | +6.8% | -2.4% | -30.2% | -96.2% | +37.6% | -41.2% | -51.6% | +10.6% | +140.2% | -11.3% | +22.0% | -48.2% | +26.0% | +92.2% | -34.2% | +4.4% | +90.6% | -27.7% | -11.6% | -23.7% | +71.6% | +27.7% | -22.0% | -16.5% | +2.4% | -2.3% | -19.2% | +101.0% | -29.8% | -8.6% | -20.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +37.6% | +3.7% | +91.2% | -36.9% | +62.9% | -34.4% | -3.9% | +72.9% | +238.3% | -63.2% | -16.2% | -9.2% | -9.8% | +17.8% | -2.6% | -3.5% | -8.3% | -3.3% | +32.4% | -9.1% | -22.1% | -1.7% | +28.4% | +13.7% | -22.3% | +3.4% | -4.0% | – | |
| – | +3.9% | +16.5% | -4.0% | +9.2% | +38.0% | +18.6% | +8.3% | -18.6% | +6.8% | -2.4% | -30.2% | -0.9% | +20.2% | +7.7% | +25.3% | -13.0% | +0.4% | -0.4% | -8.3% | +34.8% | -3.9% | -4.4% | +5.3% | -29.2% | -1.4% | +4.5% | -2.7% | +12.9% | +10.6% | -10.1% | +8.3% | -5.6% | -7.8% | +4.0% | -5.3% | -6.8% | -9.4% | +22.1% | -11.4% | – | |
| – | +10.9% | -4.2% | +5.9% | -12.3% | +5.8% | +23.9% | +24.5% | +36.6% | +44.8% | +44.4% | -9.0% | +2.5% | +12.4% | +8.1% | +0.5% | +0.4% | -0.9% | +22.7% | -3.0% | -3.9% | -1.5% | +12.2% | -3.7% | -7.2% | +0.0% | +3.6% | -4.0% | -10.7% | -0.4% | -3.7% | +5.1% | -11.1% | -1.6% | +0.6% | +4.1% | -6.6% | -14.4% | +17.2% | -2.9% | – | |
| – | +5.5% | +11.5% | -2.0% | +4.4% | +32.0% | +19.4% | +10.8% | -8.9% | +16.7% | +12.9% | -21.4% | +0.7% | +16.4% | +7.8% | +13.5% | -7.4% | +4.6% | +5.0% | -5.6% | +14.8% | -2.9% | +2.9% | +1.0% | -19.2% | -0.6% | +4.1% | -3.4% | +0.6% | +5.5% | -7.3% | +6.9% | -8.1% | -5.1% | +2.4% | -1.1% | -6.7% | -11.7% | +19.9% | -9.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -173.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.4% | +4.3% | -0.5% | +11.7% | -1.6% | +17.6% | +33.3% | +64.4% | +129.8% | +20.3% | +3.0% | +0.1% | +109.1% | +0.6% | +3.8% | +0.6% | +4.0% | -28.0% | -1.8% | +60.2% | -0.9% | -15.8% | -5.6% | -3.2% | -3.7% | -2.2% | +0.5% | +5.0% | +2.2% | -5.2% | +52.1% | +27.2% | -1.6% | -1.9% | +2.1% | -2.0% | +14.6% | -0.5% | +4.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -206.9% | – | – | – | – | – | – | – | – | – | -234.3% | – | – | – | – | – | – | – | – | |
| – | – | -83.5% | -21.7% | -27.8% | -30.8% | +33.3% | -241.7% | – | +21.4% | -41.2% | -20.0% | +150.0% | -90.0% | +3,200.0% | +107.6% | -67.9% | +40.9% | +140.3% | -10.1% | -20.9% | -214.2% | – | -6.9% | -62.8% | +62.2% | -26.0% | +135.2% | -90.6% | +983.3% | -45.4% | -5.6% | -58.2% | -489.3% | – | +11.1% | -15.0% | -297.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -206.9% | – | – | – | – | – | – | – | – | – | -234.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -173.7% | – | – | – | – | – | – | – | – | – | -162.5% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.